GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hyloris Pharmaceuticals SA (XBRU:HYL) » Definitions » Allowance For Loans And Lease Losses

Hyloris Pharmaceuticals (XBRU:HYL) Allowance For Loans And Lease Losses


View and export this data going back to 2020. Start your Free Trial

What is Hyloris Pharmaceuticals Allowance For Loans And Lease Losses?

Allowance For Loans And Lease Losses only applies to banks.


Hyloris Pharmaceuticals (XBRU:HYL) Business Description

Industry
Traded in Other Exchanges
Address
Boulevard Patience et Beaujonc N°3/1, Liege, BEL, 4000
Hyloris Pharmaceuticals SA is an early-stage specialty pharmaceutical company focused on adding value to the healthcare system by reformulating pharmaceuticals. The company develops proprietary products it believes offer advantages compared to available alternatives, to address the underserved medical needs of patients, hospitals, physicians, payors, and other stakeholders in the healthcare system. Its portfolio spans these areas such as Cardiovascular, Other Reformulations, and Established markets (high-barrier generics). It has two early commercial-stage products, Sotalol IV for the treatment of atrial fibrillation, and Maxigesic IV, a non-opioid analgesic product for the treatment of pain.